Gaingels

Founded in 2014, Gaingels is a venture investment syndicate dedicated to supporting the LGBT+ community. It invests globally in companies led by LGBT+ founders or C-suite executives at all stages of growth, focusing on inclusivity and positive social change.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***

Marc Baum

Investor

David Beatty

Managing Partner

Jesse Curran

Principal

Paul Grossinger

Investor

Todd Havill

Research Operations and Principal, Investment

Surya Jayaweera

Angel Investor

Jennifer Jeronimo

CEO and General Partner

Jake Prigoff MD

General Partner

Peter Steinberg

General Partner

Alexandra Tanner

Investor

Lorenzo Thione

Managing Director

Past deals in Maryland

VerImmune

Seed Round in 2024
VerImmune, based in Baltimore, Maryland, is an Immuno-Oncology company focused on developing innovative cancer therapies through its proprietary technology known as Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs). This first-in-class approach aims to harness and redirect pre-existing immune memory from pathogenic infections or childhood vaccines towards tumors. By doing so, VerImmune seeks to offer a transformative treatment option for patients with various types of cancers, especially those facing treatment resistance or limited therapeutic choices. The company's goal is to provide a low-toxicity solution that delivers durable benefits across a broad spectrum of cancer types.

Roomza

Seed Round in 2023
Roomza offers personalized hotel stays in prime locations like Times Square and New Orleans. Guests enjoy flexible check-in/check-out times and exclusive amenities, transforming ordinary rooms into unique experiences.

VerImmune

Seed Round in 2023
VerImmune, based in Baltimore, Maryland, is an Immuno-Oncology company focused on developing innovative cancer therapies through its proprietary technology known as Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs). This first-in-class approach aims to harness and redirect pre-existing immune memory from pathogenic infections or childhood vaccines towards tumors. By doing so, VerImmune seeks to offer a transformative treatment option for patients with various types of cancers, especially those facing treatment resistance or limited therapeutic choices. The company's goal is to provide a low-toxicity solution that delivers durable benefits across a broad spectrum of cancer types.

Previse

Seed Round in 2023
Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal (GI) cancers, particularly esophageal cancer and its precancerous condition, Barrett’s esophagus. Founded in 2018 and based in Halethorpe, Maryland, Capsulomics aims to address the diagnostic and prognostic uncertainties associated with GI diseases. By providing advanced diagnostic solutions, the company enables healthcare professionals to prevent, detect, and treat these conditions more effectively, ultimately enhancing patient outcomes.

VerImmune

Seed Round in 2022
VerImmune, based in Baltimore, Maryland, is an Immuno-Oncology company focused on developing innovative cancer therapies through its proprietary technology known as Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs). This first-in-class approach aims to harness and redirect pre-existing immune memory from pathogenic infections or childhood vaccines towards tumors. By doing so, VerImmune seeks to offer a transformative treatment option for patients with various types of cancers, especially those facing treatment resistance or limited therapeutic choices. The company's goal is to provide a low-toxicity solution that delivers durable benefits across a broad spectrum of cancer types.

Sonavi Labs

Seed Round in 2021
Founded in 2017 and headquartered in Baltimore, Maryland, Sonavi Labs is a medical technology company that develops innovative devices and software. It specializes in analyzing body sounds for disease diagnosis, utilizing artificial intelligence to enhance healthcare provider capabilities.

Protenus

Series D in 2021
Protenus, Inc. is a healthcare compliance analytics company based in Baltimore, Maryland, which was founded in 2014. The company specializes in an AI-driven platform designed to audit access to patient records across health systems in the United States. Protenus' technology identifies risks such as inappropriate access to patient data and the misuse of controlled substances by healthcare staff. By automating the detection of policy violations and other anomalous behaviors, the platform supports healthcare organizations in protecting patient privacy and reducing operational risks. Protenus is recognized for its innovation and commitment to fostering safe patient outcomes while enhancing the reputation of healthcare providers. The company has received accolades such as being named one of America's Best Startup Employers by Forbes and recognized as a Great Place to Work.

UrbanStems

Series C in 2021
UrbanStems Inc. is a Washington, D.C.-based company that specializes in on-demand flower delivery services. Founded in 2014, it offers a variety of fresh flowers and seasonal stems for different occasions, along with floral arrangements tailored for businesses. UrbanStems provides hand-crafted bouquets that are designed for quick delivery, often arriving within minutes to the recipient's location. The company's offerings include personalized notes and specific care instructions for each arrangement, enhancing the gifting experience. Additionally, UrbanStems features a subscription service for regular flower deliveries and provides an iOS application for convenient ordering. The company's services are available in major cities such as New York, Baltimore, Philadelphia, and Washington, D.C.

Qualytics

Seed Round in 2021
Qualytics is a technology company based in Baltimore, Maryland, founded in 2020, that specializes in data quality surveillance. The company has developed a platform designed to monitor and protect against data pipeline corruption. Its core technology includes a data firewall that captures erroneous data at the source, preventing it from affecting downstream data platforms. This system integrates with data pipelines and flows, alongside a surveillance hub, to ensure comprehensive monitoring. Additionally, Qualytics leverages machine learning to automatically generate and refine data rules through supervised workflows, enabling organizations to detect and respond to anomalies in real time. The platform includes active measures such as message-level quarantining to address potential issues swiftly.

Previse

Funding Round in 2020
Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal (GI) cancers, particularly esophageal cancer and its precancerous condition, Barrett’s esophagus. Founded in 2018 and based in Halethorpe, Maryland, Capsulomics aims to address the diagnostic and prognostic uncertainties associated with GI diseases. By providing advanced diagnostic solutions, the company enables healthcare professionals to prevent, detect, and treat these conditions more effectively, ultimately enhancing patient outcomes.

Sonavi Labs

Venture Round in 2020
Founded in 2017 and headquartered in Baltimore, Maryland, Sonavi Labs is a medical technology company that develops innovative devices and software. It specializes in analyzing body sounds for disease diagnosis, utilizing artificial intelligence to enhance healthcare provider capabilities.

Sonavex

Series A in 2018
Sonavex develops imaging technologies for vascular and surgical care, employing ultrasound to detect postoperative blood clots at the point of care and to measure intravascular flow metrics for timely decision making. It also develops bioresorbable, echogenic devices to mark at-risk vessels and to collect data on arteriovenous fistula flow, diameter, and depth at dialysis clinics to assess maturation and anticipate future complications. Based in Baltimore, Maryland, Sonavex focuses on delivering data-driven visualization of vessel health to improve surgical and dialysis patient outcomes.

Vixiar

Venture Round in 2018
Vixiar Medical, established in 2013 and headquartered in Annapolis, Maryland, specializes in developing non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases. Its flagship product, Indicor, is a handheld point-of-care device and digital platform designed to monitor and manage worsening heart failure. Vixiar's devices aim to enhance clinical workflow and deliver economic value to the healthcare system by enabling monitoring in various settings, including homes, offices, nursing homes, and hospitals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.